My Watchlist

Top Indices

Nasdaq Composite

SPX

My Portfolio

Co-Diagnostics, Inc. - Common Stock (NQ:CODX)

1.290 +0.030 (+2.38%)

Streaming Delayed Price Updated: 1:41 PM EDT, Aug 19, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Co-Diagnostics, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 Next >

Earnings Outlook For Co-Diagnostics ↗

August 10, 2022

Co-Diagnostics (NASDAQ:CODX) is set to give its latest quarterly earnings report on Thursday, 2022-08-11. Here's what investors need to know before the announcement. Analysts estimate that...

Via Benzinga

CODX Stock Pops as Co-Diagnostics Ships Out Monkeypox Tests ↗

July 11, 2022

CODX stock is up during early afternoon trading as Co-Diagnostics ships out monkeypox testing reagents to help deal with the outbreak.

Via InvestorPlace

5 Value Stocks To Watch In The Healthcare Sector ↗

July 11, 2022

The Meaning Behind Value Stocks A value stock is traditionally defined in terms of how investors in the marketplace are valuing that company's future growth prospects. Low P/E multiples are good base...

Via Benzinga

22 Stocks Moving in Thursday's Pre-Market Session ↗

June 23, 2022

Gainers WISeKey International Holding AG (NASDAQ: WKEY) rose 74.4% to $2.32 in pre-market trading. WISeKey International recently issued 2022 first-half revenue guidance for its IoT segment.

Via Benzinga

5 Value Stocks To Watch In The Healthcare Sector ↗

June 06, 2022

Via Benzinga

10 Biggest Price Target Changes For Monday ↗

May 16, 2022

Needham cut the price target on Carvana Co. (NYSE: CVNA) from $121 to $80. Carvana shares rose 11.3% to $42.71 in pre-market trading.

Via Benzinga

Co-Diagnostics Stock Surges As Q1 Results Surpass Street Expectations ↗

May 12, 2022

Co-Diagnostics Inc (NASDAQ: CODX) reported first-quarter revenue growth of 13.4% year-over-year to $22.7 million, beating the consensus of $20.17 million.

Via Benzinga

Recap: Co-Diagnostics Q1 Earnings ↗

May 12, 2022

Co-Diagnostics (NASDAQ:CODX) reported its Q1 earnings results on Thursday, May 12, 2022 at 04:01 PM. Here's what investors need to know about the announcement. Earnings Co-Diagnostics beat estimated...

Via Benzinga

36 Stocks Moving In Friday's Mid-Day Session ↗

March 25, 2022

Gainers Forge Global Holdings, Inc. (NYSE: FRGE) shares jumped 66.4% to $20.70. Clever Leaves Holdings Inc. (NASDAQ: CLVR) jumped 29.1% to $2.04 after the company reported...

Via Benzinga

64 Biggest Movers From Friday ↗

March 28, 2022

Gainers Clever Leaves Holdings Inc. (NASDAQ: CLVR) shares surged 143% to settle at $3.84 on Friday after the company reported better-than-expected Q4 sales results and reaffirmed...

Via Benzinga

Co-Diagnostics's Return On Capital Employed Insights ↗

March 25, 2022

Pulled from Benzinga Pro data, Co-Diagnostics (NASDAQ:CODX) posted Q4 earnings of $7.50 million, an increase from Q3 of 34.66%. Sales dropped to $20.40 million, a 32.22% decrease...

Via Benzinga

The Daily Biotech Pulse: MEI Pharma Wilts On Adverse Regulatory Development, Decision Day For Zogenix, AN2 Therapeutics IPO ↗

March 25, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours.

Via Benzinga

12 Health Care Stocks Moving In Thursday's After-Market Session ↗

March 24, 2022

Gainers

Via Benzinga

Why Co-Diagnostics Stock Is Trading Higher After Hours ↗

March 24, 2022

Co-Diagnostics Inc (NASDAQ: CODX) shares are trading higher in Thursday's after-hours session after the company reported financial results and issued earnings guidance. Co-...

Via Benzinga

The Daily Biotech Pulse: Novartis Prostate Cancer Drug Lands FDA Approval, Ligand Announces SPAC Deal To Spin Off Antibody Business, Lilly's Lung Cancer Therapy Hit With CRL ↗

March 24, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours:

Via Benzinga

Co-Diagnostics's Earnings Outlook ↗

March 23, 2022

Co-Diagnostics (NASDAQ:CODX) is set to give its latest quarterly earnings report on Thursday, 2022-03-24. Here's what investors need to know before the announcement. Analysts...

Via Benzinga

Earnings Scheduled For March 24, 2022 ↗

March 24, 2022

Companies Reporting Before The Bell • iHuman (NYSE:IH) is likely to report earnings for its fourth quarter. • Pioneer Muni High Inc (NYSE:MAV) is expected to...

Via Benzinga

5 Value Stocks To Watch In The Healthcare Sector ↗

March 21, 2022

What Defines a Value Stock? A value stock is traditionally defined in terms of how investors in the marketplace are valuing that company's future growth prospects. Low P/E...

Via Benzinga

The Week Ahead In Biotech (March 20-26): Focus On Zogenix FDA Decision, Dermatology Conference Presentations & Earnings ↗

March 20, 2022

Biotech stocks rebounded along with the broader market in the week ending March 18, as risk appetite returned. Multiple conference presentations, clinical readouts and earnings news dictated sentiment...

Via Benzinga

38 Stocks Moving In Tuesday's Mid-Day Session ↗

March 15, 2022

Gainers Incannex Healthcare Limited (NASDAQ: IXHL) shares jumped 131.6% to $53.10 after jumping 54% on Monday. Incannex Healthcare recently completed a preliminary analysis of...

Via Benzinga

68 Biggest Movers From Yesterday ↗

March 16, 2022

Gainers Sonim Technologies, Inc. (NASDAQ: SONM) shares jumped 103.3% to settle at $1.22 on Tuesday after the company announced its XP8 smartphone has integrated with the Walkie...

Via Benzinga

Why Co-Diagnostics Shares Are Trading Higher Today ↗

March 15, 2022

Co-Diagnostics Inc (NASDAQ: CODX) shares are trading higher Tuesday after the company announced its board authorized a share repurchase program, allowing Co-Diagnostics...

Via Benzinga

Abbott Labs Outlook Cools the Omicron Led Testing Boom ↗

January 28, 2022

Photo by Adam Nieścioruk on Unsplash

Via Benzinga

10 Health Care Stocks Whale Activity In Today's Session ↗

January 20, 2022

This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our...

Via Benzinga

Co-Diagnostics, Inc. JV CoSara Receives Clearance From Indian Regulators For High-Risk HPV Multiplex Test ↗

January 13, 2022

Co-Diagnostics, Inc.(NASDAQ: CODX) (the "Company"), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, announced...

Via Benzinga

34 Stocks Moving In Tuesday's Mid-Day Session ↗

January 04, 2022

Gainers TherapeuticsMD, Inc. (NASDAQ: TXMD) jumped 31.7% to $0.5185 after it announced that the FDA approved a low dose version of Bijuva, an oral hormone therapy to treat women...

Via Benzinga

12 Health Care Stocks Moving In Monday's Intraday Session ↗

December 27, 2021

Gainers Microbot Medical (NASDAQ:MBOT) stock moved upwards by 47.87% to $8.02 during Monday's regular session. The current volume of 63.6 million shares is 153229.83%...

Via Benzinga

Free COVID Tests: What Stocks Will Benefit? ↗

December 23, 2021

The government hasn’t announced yet what company or companies it will be buying from, but there are several businesses involved in producing these kits.

Via Talk Markets

18 Stocks Moving in Thursday's Pre-Market Session ↗

December 16, 2021

Gainers Calliditas Therapeutics AB (NASDAQ: CALT) rose 36.5% to $25.45 in pre-market trading after the company announced it was granted by the FDA accelerated approval of TARPEYO...

Via Benzinga

7 Stocks to Buy to Hedge Against Omicron Variant Risks ↗

December 13, 2021

With the omicron variant presenting uncertainties regarding how governments will react, here are some stocks to buy to counter that risk.

Via InvestorPlace

< Previous 1 2 3 4 5 6 7 8 9 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.